BEATHeartBeam Inc
BEAT
HeartBeam Inc5,409
Mkt Cap
$48.47MVolume
487,760.0052W High
$4.0052W Low
$0.54PE Ratio
-1.44BEAT Fundamentals
Price
$0.9294Prev Close
$0.9037Open
$0.924550D MA
$1.24Beta
1.23Avg. Volume
2.29MEPS (Annual)
-$0.6234P/B
13.93Rev/Employee
$0.00$76.52
HeartBeam (NASDAQ: BEAT) Collaborates to Advance Next-Gen ECG Solutions
HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology. The publication indicates that the move, “highlights HeartBeam’s growing focus on artificial intelligence (‘AI’)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward data-driven, remote monitoring solutions. The announcement […]
Investor Brand Network·3d ago
HeartBeam (NASDAQ: BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization
HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common stock, generating gross proceeds of $10 million before expenses, with the transaction completed on April 16, 2026. The offering, supported by key stakeholders including ClearCardio(TM), company leadership and institutional investors, will fund commercialization of HeartBeam’s FDA-cleared 12-lead synthesized ECG […]
Investor Brand Network·10d ago
HeartBeam (NASDAQ:BEAT) Director Acquires $600,000.00 in Stock
HeartBeam, Inc. (NASDAQ:BEAT - Get Free Report) Director Mark Strome purchased 750,000 shares of the firm's stock in a transaction on Thursday, April 16th. The stock was acquired at an average price...
MarketBeat·10d ago
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced it has closed its underwritten public...
Business Wire·11d ago
HeartBeam (NASDAQ: BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives
HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing an underwritten public offering of shares of its common stock or common stock equivalents, with all securities to be offered by the company and the final size and terms subject to market conditions. The company said it intends to […]
Investor Brand Network·12d ago
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public...
Business Wire·13d ago
HeartBeam Announces Proposed Public Offering of Common Stock
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that it is commencing an underwritten public...
Business Wire·13d ago
HeartBeam’s (NASDAQ: BEAT) ‘Significant Turning Point’ Spotlighted in Recent Article
HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed Joseph Gunnar & Co.’s upgrade of the company from Hold to Buy and raising of its 12-month price target to $4 from $1, citing regulatory progress and the company’s transition toward commercialization. The piece reads, “‘We upgrade HeartBeam to a BUY and High-Risk rating with […]
Investor Brand Network·26d ago
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
How Decentralized AI is Unlocking Value in Cardiac Diagnostics How Decentralized AI is Unlocking Value in Cardiac Diagnostics PR Newswire VANCOUVER,BC, March 27, 2026 ISSUED ON BEHALF OF VENTRIPOINT...
PR Newswire·1mo ago
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, has reported its financial and operational results for the...
Business Wire·2mo ago
<
1
2
...
>